000 03390nam a22003615i 4500
001 291751
003 MX-SnUAN
005 20170705134224.0
007 cr nn 008mamaa
008 150903s2005 xxk| o |||| 0|eng d
020 _a9781846280153
_99781846280153
024 7 _a10.1007/b136185
_2doi
035 _avtls000343585
039 9 _a201509031112
_bVLOAD
_c201405070503
_dVLOAD
_y201402061159
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC870-923.2
100 1 _aWaxman, Jonathan.
_eeditor.
_9306676
245 1 0 _aUrological Cancers /
_cedited by Jonathan Waxman.
264 1 _aLondon :
_bSpringer London,
_c2005.
300 _axvI, 342 páginas 45 ilustraciones
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aProstate Cancer -- The Molecular Biology of Prostate Cancer -- Familial Prostate Cancer -- Screening for Prostate Cancer -- Diet and Prostate Cancer -- Radical Radiotherapy for Prostate Cancer -- Prostate Cancer: Immediate vs. Deferred Treatment -- Surgical Treatment of Prostate Cancer -- Hormone Therapy for Prostate Cancer -- Chemotherapy in Prostate Cancer -- Proteomic Approaches to Problem Solving in Prostate Cancer -- Gene Therapy for Prostate Cancer -- Bladder Cancer -- Molecular Biology of Bladder Cancer -- Treatment Options in Superficial (pTA/pT1/CIS) Bladder Cancer -- Chemotherapy for Bladder Cancer -- Gene Therapy of Urothelial Malignancy -- Kidney Cancer -- Molecular Biology of Kidney Cancer -- Cytokine and Angiogenesis Inhibitors -- Novel Therapies for Renal Cell Cancer -- Testicular Cancer -- Genetics and Biology of Adult Male Germ Cell Tumors -- Chemotherapy for Testicular Cancer -- Surgery for Testicular Cancer -- Pathobiological Basis of Treatment Strategies of Germ Cell Tumors -- Penile Cancer -- A Scientific Understanding of the Development of Penile Tumors -- The Clinical Management of Penile Cancer -- Unusual Urological Tumors -- Oncocytomas and Rare Renal Tumors -- Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis.
520 _aOur understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations. This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781852339111
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/b136185
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c291751
_d291751